Price$1.72-0.04 (-2.55%)
01:30 PM06:30 PM
News · 26 weeks64+225%
2026-04-192026-10-11
Mix3190d
- Insider10(32%)
- SEC Filings9(29%)
- Other8(26%)
- Earnings3(10%)
- Leadership1(3%)
Latest news
25 items- PRSterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow SolutionsAdvancing how teams work more efficiently and make better-informed decisions across the patent lifecycle Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, to develop AI-enhanced patent workflow solutions. This partnership brings together Sterne Kessler’s practitioner-built technology and deep patent practice expertise with Clarivate’s leading IP data and software. Together, the organizations will develop practical, future-ready capabilities that help teams transform technical, legal and portfolio dat
- SECAmendment: SEC Form 8-K/A filed by Clarivate Plc8-K/A - CLARIVATE PLC (0001764046) (Filer)
- INSIDERSEC Form 4 filed by Clarivate Plc4 - CLARIVATE PLC (0001764046) (Issuer)
- SECSEC Form 8-K filed by Clarivate Plc8-K - CLARIVATE PLC (0001764046) (Filer)
- PRClarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic TransformationTransaction sharpens strategic focus on leading Academia & Government and Intellectual Property segmentsProceeds strengthen balance sheet and enhance financial flexibilityLONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the successful completion of the sale of its Life Sciences & Healthcare segment to Altaris, LLC ("Altaris"), advancing Clarivate's transformation and simplifying its portfolio. The transaction for $600 million was previously announced on July 6, 2026.With the completion of the transaction, Clarivate is now a more-focused subscription-first global provider of
- INSIDERDirector Cornick Kenneth L. was granted 17,215 units of Ordinary Shares and covered exercise/tax liability with 3,444 units of Ordinary Shares, increasing direct ownership by 12% to 126,457 units (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- INSIDERDirector Snyder Andrew Miles was granted 30,688 units of Ordinary Shares and covered exercise/tax liability with 1,012 units of Ordinary Shares, increasing direct ownership by 10% to 322,592 units (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- INSIDERDirector Bomba Jane L Okun covered exercise/tax liability with 181 units of Ordinary Shares and was granted 17,215 units of Ordinary Shares, increasing direct ownership by 5% to 329,635 units (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- SECClarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CLARIVATE PLC (0001764046) (Filer)
- PRClarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt SecuritiesLONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding 3.875% Senior Secured Notes due 2028 (the "Notes") for aggregate principal amount of up to $75,000,000 (the "Maximum Amount"), upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase") and any related documents (collectively with the Offer to Purchase, the "Tender
- SECClarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CLARIVATE PLC (0001764046) (Filer)
- PRClarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt SecuritiesLONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offer (the "Offer") by its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase"). The Company is offering to purchase in the O
- PRClarivate to Report Third Quarter 2026 Results on November 3, 2026LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third quarter 2026 before the market opens on Tuesday, November 3, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 8:30 AM Eastern Time on Tuesday, November 3, 2026 to review the results. The webcast is open to all interested parties and may include forwar
- SECClarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CLARIVATE PLC (0001764046) (Filer)
- PRClarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt SecuritiesNEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the "Company"), has commenced a cash tender offer (the "Offer") to purchase the outstanding notes described below, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 17, 2026 (the "Offer to Purchase"). The Company is offering to purchase in the Offer its 3.875% Senior Secured Notes due 2028 (the "Notes") for the consideration described below, subject to a $7
- PRClarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advancesLONDON, Sept. 17, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Citation Laureates 2026, a distinguished group of 22 researchers whose work is of Nobel class. Selected by experts at the Institute for Scientific Information (ISI) at Clarivate, these individuals have made pioneering contributions that continue to shape science and society. Since the program's inception, 89 Citation Laureates have gone on to receive Nobel Prizes, often ye
- PRAccuserve Solutions Appoints Maroun S. Mourad as an Independent Board MemberVeteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise to Support Accuserve’s Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Accuserve Solutions ("Accuserve" or the "Company"), an independent managed repair services platform connecting insurance carriers, homeowners, and contractors, today announced the appointment of Maroun S. Mourad as an independent member to its Board of Directors. Mr. Mourad brings nearly three decades of leadership across the property and casualty insurance, technology, and data analytics sectors, along with deep carrier relationships within the United States and internat
- INSIDERExecutive Vice President/CFO Easton Michael M was granted 194,300 units of Ordinary Shares, increasing direct ownership by 28% to 893,609 units (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- INSIDERSenior VP, CAO Lisowski Matthew J. was granted 67,357 units of Ordinary Shares, increasing direct ownership by 84% to 147,255 units (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- INSIDERChief Executive Officer Shem Tov Matitiahu S. covered exercise/tax liability with 47,633 units of Ordinary Shares, decreasing direct ownership by 2% to 2,290,782 units (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- INSIDERNew insider Lisowski Matthew J. claimed ownership of 79,898 units of Ordinary Shares (SEC Form 3)3 - CLARIVATE PLC (0001764046) (Issuer)
- INSIDERDirector Cornick Kenneth L. bought $1,671,500 worth of Ordinary Shares (900,000 units at $1.86) (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- PRClarivate Scales Agentic AI Across Cortellis to Advance Drug DevelopmentExpanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycleLONDON, Aug. 6, 2026 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the expansion of agentic AI capabilities across the Cortellis portfolio, helping life sciences R&D teams accelerate discovery, strengthen safety assessment and make faster, more informed portfolio decisions. By embedding AI directly within existing workflows, the new capabilities enable researchers to reduce manual effort, navigate complexity and focus on higher-value sc
- INSIDERDirector Snyder Andrew Miles sold $4,829,859 worth of Ordinary Shares (2,489,618 units at $1.94) (SEC Form 4)4 - CLARIVATE PLC (0001764046) (Issuer)
- SECSEC Form 144 filed by Clarivate Plc144 - CLARIVATE PLC (0001764046) (Subject)
CLVT FAQ
7 questionsWhat does Clarivate Plc do?
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and...Where does CLVT stock trade?
Clarivate Plc (CLVT) is listed on NYSE.What sector and industry is CLVT in?
Clarivate Plc operates in the Technology sector, EDP Services industry.When did Clarivate Plc go public?
Clarivate Plc (CLVT) completed its IPO in 2019.What are analysts saying about CLVT?
Clarivate Plc has had 8 recent analyst actions on file. The most recent action was from Goldman: Neutral with a $360.00 price target on 2026-01-08. Recent price targets range from $300.00 to $850.00.What companies are similar to CLVT?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), WDAY (Workday Inc.), ZS (Zscaler Inc.). Compare CLVT side-by-side with any of them on Quantisnow.How can I track CLVT on Quantisnow?
Quantisnow aggregates Clarivate Plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLVT to receive live email and push alerts on every new disclosure.